Published Date : May 04, 2016
The rise in the number of infectious diseases and infections that are spreading via blood donations is a major challenge for the blood industry. The spread of diseases such as acquired immunodeficiency syndrome (AIDS) and hepatitis via blood donation route is one of the major concerns challenging blood supply globally. Thus, an increasing number of initiatives taken by governments and increasing number of surgical procedures are driving the global blood processing devices and consumables market. The growth of this market is also supported by favorable claim policies that have been introduced worldwide and the increasing automation of blood processing devices.
The traditional methods that were used for blood processing came with numerous challenges and made it difficult for maintaining data regarding product and process control, recording and tracking, regulatory requirements, and staffing issues. Thus, automated devices such as automated cell processors and whole blood collection devices account for the largest share in the market. On the contrary, manual blood processing and collection methods have been grappling with pacing up sales volume and demand. To address this, the deployment of automated blood collection and processing devices helps with operational efficiency and save time because of which these devices are displaying high demand.
Some key features of recently introduced automated blood processing devices are as follows: